DOI QR코드

DOI QR Code

2-O-digalloyl-1,3,4,6-tetra-O-galloyl-β-D-glucose isolated from Galla Rhois suppresses osteoclast differentiation and function by inhibiting NF-κB signaling

  • Ihn, Hye Jung (Institute for Hard Tissue and Bio-tooth Regeneration (IHBR), Kyungpook National University) ;
  • Kim, Tae Hoon (Department of Food Science and Biotechnology, Daegu University) ;
  • Kim, Kiryeong (Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University) ;
  • Kim, Gi-Young (Department of Marine Life Sciences, School of Marine Biomedical Sciences, Jeju National University) ;
  • Jeon, You-Jin (Department of Marine Life Sciences, School of Marine Biomedical Sciences, Jeju National University) ;
  • Choi, Yung Hyun (Department of Biochemistry, College of Korean Medicine, Dong-Eui University) ;
  • Bae, Jong-Sup (College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University) ;
  • Kim, Jung-Eun (Department of Molecular Medicine, School of Medicine, Kyungpook National University) ;
  • Park, Eui Kyun (Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University)
  • Received : 2019.03.05
  • Accepted : 2019.04.25
  • Published : 2019.06.30

Abstract

Natural compounds isolated from medicinal herbs and plants have immense significance in maintaining bone health. Hydrolysable tannins have been shown to possess a variety of medicinal properties including antiviral, anticancer, and anti-osteoclastogenic activities. As a part of a study on the discovery of alternative agent against skeletal diseases, we isolated a hydrolysable tannin, 2-O-digalloyl-1,3,4,6-tetra-O-galloyl-${\beta}$-D-glucose (DTOGG), from Galla Rhois and examined the effect on osteoclast formation and function. We found that DTOGG significantly inhibited receptor activator of nuclear factor-${\kappa}B$ ligand (RANKL)-induced osteoclast differentiation by downregulating the expression of the key regulator in osteoclastogenesis as well as osteoclast-related genes. Analysis of RANKL/RANK signaling revealed that DTOGG impaired activation of $I{\kappa}B{\alpha}$ and p65 in the nuclear factor kappa-lightchain-enhancer of activated B cells (NF-${\kappa}B$) signaling pathway. Furthermore, DTOGG reduced bone resorbing activity of osteoclasts, compared to the vehicle-treated control. These results suggest that DTOGG could be a useful natural compound to manage osteoclast-mediated skeletal diseases.

Keywords

References

  1. Chambers TJ (2000) Regulation of the differentiation and function of osteoclasts. J Pathol 192, 4-13 https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q
  2. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289, 1504-1508 https://doi.org/10.1126/science.289.5484.1504
  3. Boyle WJ, Simonet WS and Lacey DL (2003) Osteoclast differentiation and activation. Nature 423, 337-342 https://doi.org/10.1038/nature01658
  4. Feng X and Teitelbaum SL (2013) Osteoclasts: New Insights. Bone Res 1, 11-26 https://doi.org/10.4248/BR201301003
  5. Takayanagi H, Kim S, Koga T et al (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 https://doi.org/10.1016/S1534-5807(02)00369-6
  6. Nakashima T and Takayanagi H (2011) New regulation mechanisms of osteoclast differentiation. Ann N Y Acad Sci 1240, E13-18 https://doi.org/10.1111/j.1749-6632.2011.06373.x
  7. Choi JG, Mun SH, Chahar HS et al (2014) Methyl gallate from Galla rhois successfully controls clinical isolates of Salmonella infection in both in vitro and in vivo systems. PLoS One 9, e102697 https://doi.org/10.1371/journal.pone.0102697
  8. Djakpo O and Yao W (2010) Rhus chinensis and Galla Chinensis--folklore to modern evidence: review. Phytother Res 24, 1739-1747 https://doi.org/10.1002/ptr.3215
  9. Yim NH, Gu MJ, Hwang YH, Cho WK and Ma JY (2016) Water extract of Galla Rhois with steaming process enhances apoptotic cell death in human colon cancer cells. Integr Med Res 5, 284-292 https://doi.org/10.1016/j.imr.2016.10.001
  10. Kwon OJ, Bae JS, Lee HY et al (2013) Pancreatic lipase inhibitory gallotannins from Galla Rhois with inhibitory effects on adipocyte differentiation in 3T3-L1 cells. Molecules 18, 10629-10638 https://doi.org/10.3390/molecules180910629
  11. Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M and March L (2008) The impact of obesity on the musculoskeletal system. Int J Obes (Lond) 32, 211-222 https://doi.org/10.1038/sj.ijo.0803715
  12. Hsu YH, Venners SA, Terwedow HA et al (2006) Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 83, 146-154 https://doi.org/10.1093/ajcn/83.1.146
  13. Li J, Zeng L, Xie J et al (2015) Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops. Sci Rep 5, 17605 https://doi.org/10.1038/srep17605
  14. Samuels JS, Shashidharamurthy R and Rayalam S (2018) Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway. Nutr Metab (Lond) 15, 42 https://doi.org/10.1186/s12986-018-0277-8
  15. Choi SW, Kim SH, Lee KS et al (2017) Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis. Evid Based Complement Alternat Med 2017, 6072573
  16. Matsubara T, Kokabu S, Nakatomi C et al (2018) The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts. Mol Cell Biol 38
  17. Asagiri M, Sato K, Usami T et al (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202, 1261-1269 https://doi.org/10.1084/jem.20051150
  18. Wada T, Nakashima T, Hiroshi N and Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12, 17-25 https://doi.org/10.1016/j.molmed.2005.11.007
  19. An J, Hao D, Zhang Q et al (2016) Natural products for treatment of bone erosive diseases: The effects and mechanisms on inhibiting osteoclastogenesis and bone resorption. Int Immunopharmacol 36, 118-131 https://doi.org/10.1016/j.intimp.2016.04.024
  20. Cai Y, Zhang J, Chen NG et al (2017) Recent Advances in Anticancer Activities and Drug Delivery Systems of Tannins. Med Res Rev 37, 665-701 https://doi.org/10.1002/med.21422
  21. Formagio AS, Volobuff CR, Santiago M, Cardoso CA, Vieira Mdo C and Valdevina Pereira Z (2014) Evaluation of Antioxidant Activity, Total Flavonoids, Tannins and Phenolic Compounds in Psychotria Leaf Extracts. Antioxidants (Basel) 3, 745-757 https://doi.org/10.3390/antiox3040745
  22. Ueda K, Kawabata R, Irie T, Nakai Y, Tohya Y and Sakaguchi T (2013) Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a broad range of viruses. PLoS One 8, e55343 https://doi.org/10.1371/journal.pone.0055343
  23. Yavropoulou MP and Yovos JG (2008) Osteoclastogenesis--current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8, 204-216
  24. Yagi M, Miyamoto T, Sawatani Y et al (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202, 345-351 https://doi.org/10.1084/jem.20050645
  25. Gowen M, Lazner F, Dodds R et al (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14, 1654-1663 https://doi.org/10.1359/jbmr.1999.14.10.1654
  26. Asagiri M and Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40, 251-264 https://doi.org/10.1016/j.bone.2006.09.023
  27. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A and Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3, 1285-1289 https://doi.org/10.1038/nm1197-1285
  28. Boyce BF, Xing L, Franzoso G and Siebenlist U (1999) Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone 25, 137-139 https://doi.org/10.1016/S8756-3282(99)00105-2
  29. Park EK, Kim MS, Lee SH et al (2004) Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation. Biochem Biophys Res Commun 325, 1472-1480 https://doi.org/10.1016/j.bbrc.2004.10.197
  30. Ihn HJ, Lee T, Kim JA et al (2017) OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo. PLoS One 12, e0170159 https://doi.org/10.1371/journal.pone.0170159
  31. Ihn HJ, Lee T, Lee D et al (2018) A novel benzamide derivative protects ligature-induced alveolar bone erosion by inhibiting NFATc1-mediated osteoclastogenesis. Toxicol Appl Pharmacol 355, 9-17 https://doi.org/10.1016/j.taap.2018.06.017
  32. Kim JA, Choi YA, Yun HS, Bae YC, Shin HI and Park EK (2016) Extracellular calcium-binding peptide-modified ceramics stimulate regeneration of calvarial bone defects. Tissue Eng Regen Med 13, 57-65 https://doi.org/10.1007/s13770-015-9066-x
  33. Imran KM, Yoon D, Lee TJ and Kim YS (2018) Medicarpin induces lipolysis via activation of Protein Kinase A in brown adipocytes. BMB Rep 51, 249-254 https://doi.org/10.5483/BMBRep.2018.51.5.228
  34. Jin SH, Kim H, Gu DR et al (2018) Actin-binding LIM protein 1 regulates receptor activator of $NF-{\kappa}B$ ligand-mediated osteoclast differentiation and motility. BMB Rep 51, 356-361 https://doi.org/10.5483/BMBRep.2018.51.7.106
  35. Ihn HJ, Kim JA, Bae YC, Shin HI, Baek MC and Park EK (2017) Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways. BMB Rep 50, 150-155 https://doi.org/10.5483/BMBRep.2017.50.3.223